NVO20251107C44.5
NVO Nov 7 2025 44.50 Call (NVO251107C00044500)
option OPRA

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.